CIBC Downgrades DexCom (DXCM) to Underperformer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $78.62 --0%
Rating Summary:
33 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 7
Rating Summary:
33 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 7
Join SI Premium – FREE
CIBC downgraded DexCom (NASDAQ: DXCM) from Neutral to Underperformer.
For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.
Shares of DexCom closed at $142.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dexcom G7 15 Day glucose monitor to launch in Canada in November
- CIBC Starts Telesat Corp (TSAT) at Outperformer, 'Clearing The Way For Lightspeed'
- Barclays Downgrades PayPal (PYPL) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
CIBCSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
